IRIS
SCIONTI, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.229
AS - Asia 940
EU - Europa 762
SA - Sud America 144
AF - Africa 45
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 3.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.167
SG - Singapore 392
IT - Italia 369
CN - Cina 156
IN - India 120
BR - Brasile 112
DE - Germania 97
GB - Regno Unito 87
VN - Vietnam 83
FI - Finlandia 51
CA - Canada 38
SE - Svezia 34
HK - Hong Kong 33
NL - Olanda 28
PK - Pakistan 26
JO - Giordania 23
ID - Indonesia 22
ES - Italia 16
MX - Messico 16
RU - Federazione Russa 16
ZA - Sudafrica 15
BD - Bangladesh 13
FR - Francia 12
EG - Egitto 11
CZ - Repubblica Ceca 10
SA - Arabia Saudita 9
TR - Turchia 9
CO - Colombia 8
LT - Lituania 8
AE - Emirati Arabi Uniti 7
AR - Argentina 7
IQ - Iraq 7
PT - Portogallo 7
AU - Australia 6
NG - Nigeria 6
PE - Perù 6
EC - Ecuador 5
ET - Etiopia 5
IE - Irlanda 5
IR - Iran 5
LB - Libano 5
CY - Cipro 4
KE - Kenya 4
MY - Malesia 4
RO - Romania 4
BG - Bulgaria 3
GT - Guatemala 3
JP - Giappone 3
MA - Marocco 3
PH - Filippine 3
PS - Palestinian Territory 3
UA - Ucraina 3
AL - Albania 2
AT - Austria 2
AZ - Azerbaigian 2
CH - Svizzera 2
EU - Europa 2
HN - Honduras 2
HR - Croazia 2
KR - Corea 2
KZ - Kazakistan 2
LK - Sri Lanka 2
PY - Paraguay 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
CL - Cile 1
EE - Estonia 1
GE - Georgia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
NZ - Nuova Zelanda 1
PL - Polonia 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
Totale 3.130
Salva come PNG Salva come JPEG
Città #
Singapore 192
Chandler 161
Ashburn 119
San Jose 116
Dallas 87
Munich 72
Santa Clara 65
Bengaluru 57
Hefei 56
Chicago 55
London 48
Milan 39
Ho Chi Minh City 36
Turku 35
Lawrence 34
Princeton 34
Beijing 31
Catanzaro 27
Hong Kong 23
Los Angeles 20
Boardman 19
Ottawa 19
Helsinki 16
Amman 15
Wilmington 15
Hanoi 14
Rome 13
Carbonia 12
New York 12
San Nicola Manfredi 12
San Francisco 10
Spezzano della Sila 10
The Dalles 10
Atlanta 9
Brooklyn 9
São Paulo 9
Delhi 8
Irbid 8
Madrid 8
Naples 8
Olomouc 8
Palermo 8
Chennai 7
Cosenza 7
Da Nang 7
Kaunas 7
Bari 6
Catania 6
Des Moines 6
Ercolano 6
Frankfurt am Main 6
Hyderabad 6
Redmond 6
Afragola 5
Aversa 5
Cardiff 5
Council Bluffs 5
Dhaka 5
Islamabad 5
Johannesburg 5
Lahore 5
Lucknow 5
Meppel 5
Pune 5
Riyadh 5
Sacramento 5
Santo Stefano di Rogliano 5
Seattle 5
Stockholm 5
Addis Ababa 4
Ahmedabad 4
Ankara 4
Brescia 4
Cape Town 4
Florianópolis 4
Haiphong 4
Jeddah 4
Kuala Lumpur 4
Manchester 4
Montreal 4
Nairobi 4
Nicosia 4
Phoenix 4
Toronto 4
Tubarão 4
Acquaviva delle Fonti 3
Ajman 3
Amsterdam 3
Andover 3
Banyumas 3
Berlin 3
Bologna 3
Bristol 3
Campo Grande 3
Castrovillari 3
Charlotte 3
Chía 3
Decollatura 3
Dubai 3
Faisalabad 3
Totale 1.818
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 417
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 123
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 99
miR-22 suppresses DNA ligase III addiction in multiple myeloma 99
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 83
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 76
A 46,XY Female with a 9p24.3p24.1 Deletion and a 8q24.11q24.3 Duplication: A Case Report and Review of the Literature. 72
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 71
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 69
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 66
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 65
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 62
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 62
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. (CO-FIRST AUTHOR) 58
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 58
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties 57
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 56
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 56
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 55
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 55
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 54
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 53
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 53
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 52
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 50
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 49
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 49
A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth 48
GENETIC SUSCEPTIBILITY TO GASTROINTESTINAL SYMPTOMS IN FABRY DISEASE 47
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 47
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 46
Modeling UGT2B7 and NR1I3 genes through multilayer network to highlight hidden link with taxane neurotoxicity 45
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 45
The Cytoscan HD Array in the Diagnosis of Neurodevelopmental Disorders 45
Mmrf-commpass data integration and analysis for identifying prognostic markers 45
Integration of DNA Microarray with Clinical and Genomic Data 44
DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine 43
null 43
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 42
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 42
Ethical Perspectives on Pharmacogenomic Profiling 41
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 41
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 40
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 40
The Effect of Physical Activity/Exercise on miRNA Expression and Function in Non-Communicable Diseases-A Systematic Review 38
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 35
Exploring the impact of lipid droplets on the evolution and progress of hepatocarcinoma 35
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 33
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy. (IF 5.168) 31
null 31
Advances in Alport syndrome diagnosis using next-generation sequencing 29
Tools in Pharmacogenomics Biomarker Identification for Cancer Patients 27
TERRA G-quadruplex stabilization behind the anti-multiple myeloma activity: Novel insights about resveratrol pleiotropic effects 25
The potential role of miRNAs in multiple myeloma therapy 25
Functional Role of Linc-RNAs in Multiple Myeloma: Linc-MIR17HG Affects Fatty Acid Biosynthesis Via transcriptional Regulation of ACC1 with Potential Therapeutic Implications 22
GPER1 Activation Exerts Anti-Tumor Activity in Multiple Myeloma 21
Raman spectroscopic characterization of liver steatosis and fibrosis in a 2D and 3D in vitro thyroxine-treated hypothyroid cellular model 17
High frequency of COH1 intragenic deletions and duplications detected by MLPA in patients with Cohen syndrome 16
Clinical Implementation of Sustainable Functional Foods and Nutraceuticals in Metabolic Health: A Feasibility Study 9
Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92 3
Totale 3.260
Salva come PNG Salva come JPEG
Categoria #
all - tutte 24.940
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.940
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 6 7 9 12 1 0
2021/2022156 1 0 0 32 8 0 8 29 36 19 17 6
2022/2023453 75 31 22 19 59 40 7 33 60 33 49 25
2023/2024511 91 40 46 35 48 74 28 41 10 17 31 50
2024/2025976 92 33 33 50 62 126 73 60 56 23 156 212
2025/20261.042 130 173 147 191 168 95 138 0 0 0 0 0
Totale 3.260